These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 26858388)

  • 1. Combining Global Elimination Of Measles And Rubella With Strengthening Of Health Systems In Developing Countries.
    Andrus JK; Cochi SL; Cooper LZ; Klein JD
    Health Aff (Millwood); 2016 Feb; 35(2):327-33. PubMed ID: 26858388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles and rubella eradication in the Americas.
    Andrus JK; de Quadros CA; Solórzano CC; Periago MR; Henderson DA
    Vaccine; 2011 Dec; 29 Suppl 4():D91-6. PubMed ID: 22185837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research priorities for accelerating progress toward measles and rubella elimination identified by a cross-sectional web-based survey.
    Kriss JL; Grant GB; Moss WJ; Durrheim DN; Shefer A; Rota PA; Omer SB; Masresha BG; Mulders MN; Hanson M; Linkins RW; Goodson JL
    Vaccine; 2019 Sep; 37(38):5745-5753. PubMed ID: 30898393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards elimination of measles and rubella in Italy: Progress and challenges.
    Adamo G; Baccolini V; Massimi A; Barbato D; Cocchiara R; Di Paolo C; Mele A; Cianfanelli S; Angelozzi A; Castellani F; Salerno C; Isonne C; Bella A; Filia A; Del Manso M; Baggieri M; Nicoletti L; Magurano F; Iannazzo S; Marzuillo C; Villari P
    PLoS One; 2019; 14(12):e0226513. PubMed ID: 31841530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles elimination: progress, challenges and implications for rubella control.
    Cutts FT; Lessler J; Metcalf CJ
    Expert Rev Vaccines; 2013 Aug; 12(8):917-32. PubMed ID: 23984961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transitioning Lessons Learned and Assets of the Global Polio Eradication Initiative to Global and Regional Measles and Rubella Elimination.
    Kretsinger K; Strebel P; Kezaala R; Goodson JL
    J Infect Dis; 2017 Jul; 216(suppl_1):S308-S315. PubMed ID: 28838195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strengthening routine immunization through measles-rubella elimination.
    Biellik RJ; Orenstein WA
    Vaccine; 2018 Sep; 36(37):5645-5650. PubMed ID: 30041881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Slow Progress In Finalizing Measles And Rubella Elimination In The European Region.
    Biellik R; Davidkin I; Esposito S; Lobanov A; Kojouharova M; Pfaff G; Santos JI; Simpson J; Mamou MB; Butler R; Deshevoi S; Huseynov S; Jankovic D; Shefer A
    Health Aff (Millwood); 2016 Feb; 35(2):322-6. PubMed ID: 26858387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
    Thompson KM; Badizadegan ND
    Risk Anal; 2017 Jun; 37(6):1109-1131. PubMed ID: 28561947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global Measles and Rubella Laboratory Network Support for Elimination Goals, 2010-2015.
    Mulders MN; Rota PA; Icenogle JP; Brown KE; Takeda M; Rey GJ; Ben Mamou MC; Dosseh AR; Byabamazima CR; Ahmed HJ; Pattamadilok S; Zhang Y; Gacic-Dobo M; Strebel PM; Goodson JL
    MMWR Morb Mortal Wkly Rep; 2016 May; 65(17):438-42. PubMed ID: 27148917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles and rubella elimination: learning from polio eradication and moving forward with a diagonal approach.
    Goodson JL; Alexander JP; Linkins RW; Orenstein WA
    Expert Rev Vaccines; 2017 Dec; 16(12):1203-1216. PubMed ID: 29037086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The State of Measles and Rubella in the WHO European region.
    Muscat M; Ben Mamou M; Shefer A; Jankovic D; Deshevoy S; Butler R
    Rev Esp Salud Publica; 2015; 89(4):345-51. PubMed ID: 26580789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance and vaccination coverage of measles and rubella in Northern Italy.
    Amendola A; Bubba L; Piralla A; Binda S; Zanetti A; Pariani E; Ranghiero A; Premoli M; Pellegrinelli L; Coppola L; Gramegna M; Baldanti F; Zanetti A
    Hum Vaccin Immunother; 2015; 11(1):206-13. PubMed ID: 25483537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measles and Rubella Global Strategic Plan 2012-2020 midterm review report: Background and summary.
    Orenstein WA; Cairns L; Hinman A; Nkowane B; Olivé JM; Reingold AL
    Vaccine; 2018 Jan; 36 Suppl 1():A35-A42. PubMed ID: 29307368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global landscape of measles and rubella surveillance.
    Patel MK; Gibson R; Cohen A; Dumolard L; Gacic-Dobo M
    Vaccine; 2018 Nov; 36(48):7385-7392. PubMed ID: 30318167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roadmap to elimination standard measles and rubella surveillance.
    Wkly Epidemiol Rec; 2017 Mar; 92(9-10):97-105. PubMed ID: 28262010
    [No Abstract]   [Full Text] [Related]  

  • 17. Measles eradication: recommendations from a meeting cosponsored by the World Health Organization, the Pan American Health Organization, and CDC.
    MMWR Recomm Rep; 1997 Jun; 46(RR-11):1-20. PubMed ID: 9213745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The end of measles and congenital rubella: an achievable dream?
    Adamo G; Sturabotti G; D'Andrea E; Baccolini V; Romano F; Iannazzo S; Marzuillo C; Villari P
    Ann Ig; 2017; 29(1):1-26. PubMed ID: 28067934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measles and rubella eradication.
    Hinman AR
    Vaccine; 2018 Jan; 36(1):1-3. PubMed ID: 29183733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global measles elimination efforts: the significance of measles elimination in the United States.
    Strebel PM; Henao-Restrepo AM; Hoekstra E; Olive JM; Papania MJ; Cochi SL
    J Infect Dis; 2004 May; 189 Suppl 1():S251-7. PubMed ID: 15106119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.